A single-center, randomized, placebo-controlled single & multiple ascending dose study in healthy subjects to study the safety, tolerability, food effect, pharmacokinetics and target engagement of the second-generation O-GlcNAcase inhibitor ASN121151

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Dirk
Principal Investigator Last Name
Beher
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$2,200,000
Funding Organization
Agency/Funding Organization
Funding Organization Country